Bipolar disorder: open trials in Israel

• NCT07140913

  A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

  Trial Treatment · Phase 3 · Bristol-Myers Squibb

  Barzilai Medical Center, Ashkelon · Be'er Sheva Mental Health Center, Beersheba · Shalvata Mental Health Center, Hod HaSharon · Jerusalem · Sheba medical center, Ramat Gan

  Registry updated 2026-11-03

• NCT06929273

  A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

  Trial Treatment · Phase 3 · Bristol-Myers Squibb

  Barzilai Medical Center, Ashkelon · Be'er Sheva Mental Health Center, Beersheba · Shalvata Mental Health Center, Hod HaSharon · Kfar Shaul Mental Health Center, Jerusalem · Jerusalem · Ness Ziona Mental Health Center, Ness Ziona · Petah Tikva · Sheba medical center, Ramat Gan

  Registry updated 2026-10-26

• NCT06951711

  A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

  Trial Treatment · Phase 3 · Bristol-Myers Squibb

  Be'er Sheva Mental Health Center, Beersheba · Shalvata Mental Health Center, Hod HaSharon · Kfar Shaul Mental Health Center, Jerusalem · Ness Ziona Mental Health Center, Ness Ziona · Petah Tikva · Sheba medical center, Ramat Gan

  Registry updated 2026-10-20

• NCT07185815

  Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

  Trial Treatment · Phase 1/2 · Mapi Pharma Ltd.

  Mapi Pharma Investigational Site IL-004, Beersheba · Mapi Pharma Investigational Site IL-003, Ness Ziona · Mapi Pharma Investigational Site IL-005, Ramat Gan · Mapi Pharma Investigational Site IL-001, Tel Aviv

  Registry updated 2026-05-01

All Bipolar disorder trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error